Peripheral inflammation is associated with remote global gene expression changes in the brain

Journal of Neuroinflammation

Volumn 11, Issue , 2014, Pages

  Thomson, Carolyn A ^a   McColl, Alison ^a   Cavanagh, Jonathan ^a   Graham, Gerard J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

cytokines; innate immunity; interferon stimulated genes; interferons; lipopolysaccharide; neuroimmune communication; neuroinflammation; systemic inflammation; toll like receptor ligation

Indexed keywords

IMIQUIMOD; INTERFERON STIMULATED GENE PROTEIN; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; NUCLEIC ACID BINDING PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; 12-O-UNDECADIENOYLPHORBOL-13-ACETATE; CYTOKINE; ENDOTOXIN; INTERFERON REGULATORY FACTOR; PHORBOL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; BRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DERMATITIS; GENE EXPRESSION; GENE INDUCTION; GENE TARGETING; GENETIC ASSOCIATION; MICROARRAY ANALYSIS; MOUSE; MURINE MODEL; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; POLYMERASE CHAIN REACTION; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; DISEASE MODEL; DNA MICROARRAY; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; SKIN; TIME; TOXICITY;

ANIMALS; BRAIN; CYTOKINES; DISEASE MODELS, ANIMAL; ENDOTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INFLAMMATION; INTERFERON REGULATORY FACTORS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHORBOL ESTERS; SKIN; TIME FACTORS;

EID: 84899475081     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-11-73     Document Type: Article

References (39)

1. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008, 9:46-56. 10.1038/nrn2297, 2919277, 18073775.
2. Addolorato G, Capristo E, Stefanini GF, Gasbarrini G. Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand J Gastroenterol 1997, 32:1013-1021. 10.3109/00365529709011218, 9361174.
3. Dickens C, McGowan L, Clark-Carter D, Creed F. Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosom Med 2002, 64:52-60.
4. Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, Lalla D, Woolley M, Jahreis A, Zitnik R, Cella D, Krishnan R, Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 2007, 367:29-35.
5. Chai Z, Gatti S, Toniatti C, Poli V, Bartfai T. Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 β: a study on IL-6-deficient mice. J Exp Med 1996, 183:311-316. 10.1084/jem.183.1.311, 2192408, 8551238.
6. Bluthé RM, Pawlowski M, Suarez S, Parnet P, Pittman Q, Kelley KW, Dantzer R. Synergy between tumor necrosis factor α and interleukin-1 in the induction of sickness behavior in mice. Psychoneuroendocrinology 1994, 19:197-207. 10.1016/0306-4530(94)90009-4, 8190839.
7. Dantzer R. Cytokine-induced sickness behavior: where do we stand?. Brain Behav Immun 2001, 15:7-24. 10.1006/brbi.2000.0613, 11259077.
8. Kraus MR, Schäfer A, Faller H, Csef H, Scheurlen M. Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy. J Clin Psychiatry 2003, 64:708-714. 10.4088/JCP.v64n0614, 12823087.
9. Kraus MR, Schäfer A, Schöttker K, Keicher C, Weissbrich B, Hofbauer I, Scheurlen M. Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study. Gut 2008, 57:531-536.
10. Miyaoka H, Otsubo T, Kamijima K, Ishii M, Onuki M, Mitamura K. Depression from interferon therapy in patients with hepatitis C. Am J Psychiatry 1999, 156:1120.
11. Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S, Goodkin RS, Greiner K, Nemeroff CB, Miller AH. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 2001, 344:961-966. 10.1056/NEJM200103293441303, 11274622.
12. Neilley LK, Goodin DS, Goodkin DE, Hauser SL. Side effect profile of interferon beta-lb in MS: results of an open label trial. Neurology 1996, 46:552-553. 10.1212/WNL.46.2.552, 8614531.
13. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006, 27:24-31. 10.1016/j.it.2005.11.006, 3392963, 16316783.
14. How to Design a Successful Microarray Experiment. [http://www.brc.dcs.gla.ac.uk/~rb106x/microarray_tips.htm].
15. van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD, Cornelissen F, Mus AM, Florencia E, Prens EP, Lubberts E. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 2009, 182:5836-5845. 10.4049/jimmunol.0802999, 19380832.
16. Glasgow Polyomics Glasgow Polyomics. [http://www.gla.ac.uk/colleges/mvls/researchinstitutes/gpf], Glasgow Polyomics.
17. DAVID Bioinformatics Resources 6.7. [http://david.abcc.ncifcrf.gov/].
18. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nat Protocols 2008, 4:44-57.
19. Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009, 37:1-13. 10.1093/nar/gkn923, 2615629, 19033363.
20. Ingenuity®. [http://www.ingenuity.com].
21. McKimmie CS, Fazakerley JK. In response to pathogens, glial cells dynamically and differentially regulate toll-like receptor gene expression. J Neuroimmunol 2005, 169:116-125. 10.1016/j.jneuroim.2005.08.006, 16146656.
22. Jones KL, Mansell A, Patella S, Scott BJ, Hedger MP, de Kretser DM, Phillips DJ. Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. Proc Natl Acad Sci 2007, 104:16239-16244. 10.1073/pnas.0705971104, 2042191, 17911255.
23. Nadeau S, Rivest S. Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier. Neuroscience 1999, 93:1449-1464. 10.1016/S0306-4522(99)00225-0, 10501470.
24. Quan N, Whiteside M, Herkenham M. Time course and localization patterns of interleukin-1β messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience 1998, 83:281-293. 10.1016/S0306-4522(97)00350-3, 9466417.
25. Buttini M, Boddeke H. Peripheral lipopolysaccharide stimulation induces interleukin-1β messenger RNA in rat brain microglial cells. Neuroscience 1995, 65:523-530. 10.1016/0306-4522(94)00525-A, 7777165.
26. Serrats J, Schiltz JC, García-Bueno B, van Rooijen N, Reyes TM, Sawchenko PE. Dual roles for perivascular macrophages in immune-to-brain signaling. Neuron 2010, 65:94-106. 10.1016/j.neuron.2009.11.032, 2873837, 20152116.
27. Liew FY, Xu D, Brint EK, O'Neill LA. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 2005, 5:446-458. 10.1038/nri1630, 15928677.
28. Foster SL, Hargreaves DC, Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 2007, 447:972-978.
29. Chen R, Zhou H, Beltran J, Malellari L, Chang SL. Differential expression of cytokines in the brain and serum during endotoxin tolerance. J Neuroimmunol 2005, 163:53-72. 10.1016/j.jneuroim.2005.02.012, 15885308.
30. Faggioni R, Fantuzzi G, Villa P, Buurman W, van Tits LJ, Ghezzi P. Independent down-regulation of central and peripheral tumor necrosis factor production as a result of lipopolysaccharide tolerance in mice. Infect Immun 1995, 63:1473-1477. 173177, 7890412.
31. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004, 4:499-511. 10.1038/nri1391, 15229469.
32. Nakajima K, Kanda T, Takaishi M, Shiga T, Miyoshi K, Nakajima H, Kamijima R, Tarutani M, Benson JM, Elloso MM, Gutshall LL, Naso MF, Iwakura Y, DiGiovanni J, Sano S. Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model. J Immunol 2011, 186:4481-4489. 10.4049/jimmunol.1000148, 21346238.
33. Skelly DT, Hennessy E, Dansereau MA, Cunningham C. A systematic analysis of the peripheral and CNS effects of systemic LPS, IL-1β, TNF-α and IL-6 challenges in C57BL/6 mice. PLoS One 2013, 8:e69123. 10.1371/journal.pone.0069123, 3698075, 23840908.
34. Leung PY, Stevens SL, Packard AE, Lessov NS, Yang T, Conrad VK, van den Dungen NN, Simon RP, Stenzel-Poore MP. Toll-like receptor 7 preconditioning induces robust neuroprotection against stroke by a novel type I interferon-mediated mechanism. Stroke 2012, 43:1383-1389. 10.1161/STROKEAHA.111.641522, 3943206, 22403050.
35. Banks WA, Robinson SM. Minimal penetration of lipopolysaccharide across the murine blood-brain barrier. Brain Behav Immun 2010, 24:102-109. 10.1016/j.bbi.2009.09.001, 2789209, 19735725.
36. Laflamme N, Soucy GV, Rivest S. Circulating cell wall components derived from Gram-negative, not Gram-positive, bacteria cause a profound induction of the gene-encoding Toll-like receptor 2 in the CNS. J Neurochem 2001, 79:648-657.
37. Field R, Campion S, Warren C, Murray C, Cunningham C. Systemic challenge with the TLR3 agonist poly I:C induces amplified IFNα/β and IL-1β responses in the diseased brain and exacerbates chronic neurodegeneration. Brain Behav Immun 2010, 24:996-1007. 10.1016/j.bbi.2010.04.004, 3334265, 20399848.
38. Konat GW, Borysiewicz E, Fil D, James I. Peripheral challenge with double-stranded RNA elicits global up-regulation of cytokine gene expression in the brain. J Neurosci Res 2009, 87:1381-1388. 10.1002/jnr.21958, 19115408.
39. Damm J, Wiegand F, Harden LM, Gerstberger R, Rummel C, Roth J. Fever, sickness behavior, and expression of inflammatory genes in the hypothalamus after systemic and localized subcutaneous stimulation of rats with the toll-like receptor 7 agonist Imiquimod. Neuroscience 2012, 201:166-183.